Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders??? Equity (Deficit)

v3.21.1
Condensed Consolidated Statements of Stockholders’ Equity (Deficit) - USD ($)
Total
Series A Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income
Beginning balance (in shares) at Dec. 31, 2019   0 67,105,000      
Beginning balance at Dec. 31, 2019 $ (34,913,110) $ 0 $ 67,105 $ 143,826,315 $ (178,806,530) $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock options and warrants exercised, and vesting of restricted shares (in shares)     432,112      
Stock options and warrants exercised, and vesting of restricted shares 243,000   $ 432 242,568    
Common stock issued for preferred stock dividends (in shares)     308,642      
Common stock issued for preferred stock dividends 500,000   $ 309 499,691    
Conversion of convertible notes (in shares)     1,546,889      
Conversion of convertible notes 5,193,552   $ 1,547 5,192,005    
Common stock issued for interest on convertible notes (in shares)     101,193      
Common stock issued for interest on convertible notes 264,212   $ 101 264,111    
Stock-based compensation 859,027     859,027    
Net (loss) income 4,756,691       4,756,691  
Other comprehensive income 1,100,000         1,100,000
Ending balance (in shares) at Mar. 31, 2020   0 69,493,836      
Ending balance at Mar. 31, 2020 (21,996,628) $ 0 $ 69,494 150,883,717 (174,049,839) 1,100,000
Beginning balance (in shares) at Dec. 31, 2020   0 121,922,532      
Beginning balance at Dec. 31, 2020 395,204,334 $ 0 $ 121,923 504,112,442 (109,030,031) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock options and warrants exercised, and vesting of restricted shares (in shares)     1,332,321      
Stock options and warrants exercised, and vesting of restricted shares 14,220   $ 1,332 12,888    
Stock-based compensation 892,428     892,428    
Net (loss) income (120,506,771)       (120,506,771)  
Ending balance (in shares) at Mar. 31, 2021   0 123,254,853      
Ending balance at Mar. 31, 2021 $ 275,604,211 $ 0 $ 123,255 $ 505,017,758 $ (229,536,802) $ 0